Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, September 19, 2026

Back to today

Pacific Health Care Organization - OTC:PFHO

Pacific Health Care trades below its more than $1 per-share net cash despite profitable workers’ compensation claims services, California HCO licenses and a tightly held OTC float.

PFHO $12M
Obscure Stocks 3 clicks

From X

@Fierce__beast

Fierce_beast on X

Comedian talking sense about $JMKE. Just like how Wendy's went to shredded lettuce instead of Iceburg, $JMKE sandwich quality started deteriorating 2 years ago according to this guy. Not counting them out, but not looking great. I made this mistake of buying $JOAN after it IPO'd. Amazing growth, amazing margins, 12x P/E! Of course it was being undermaintained and quality quickly deteriorated post-covid. Beware of private equity and short-term oriented management teams.
@Fierce__beast

Fierce_beast on X

$INMD has 8.5/sh of cash, a 14.5/sh stock price, and around my estimate of .7/sh of eps after accounting for capital requirements and excluding interest income. If this is right, that means it's trading around 8x p/e (6/.7) for just the operating business. Even if you thought it should only be 4x p/e (3/.7), that's 3$ of downside (20%) on a 14.5/sh stock. Vice versa, if you thought it should be 12x p/e (8.4/.7), that's 2.4$ of upside (16%) on a 14.5/sh stock. Suppose a rational stock market investor requires a 9% return, and if he valued a stock at 8x p/e, that multiple would be consistent with a perpetual earnings decline around 3% annually. For a 4x p/e that rate would be closer to 13%. Should we value INMD's future cash stream at an 8x NTM P/E, above, or below? INMD's earnings seems to be declining much faster than 3% annually, even faster than 11% annually. There seems to be a lot of competition, a lot of issues with their strategy, constnat negative revisions, constant missed promises and dissapointments. Wonder what's going on underneath
@blondesnmoney

Cluseau Investments on X

Disclaimer: I have sold this position and have no view on the valuation or future prospects My craziest OTC adventure this year was discovering a single-asset refinery that sells Jet Fuel to the US Military. It sounds kinda crazy, but it's the exact type of ridiculous setup funny enough to look into. In July, refining crack spreads were blowing out, and nearly every refiner $PBF, $PARR, $VLO, $PSX were steamrolling. I wanted some exposure, but I felt sheepish chasing names that were already tearing it up. I started looking at smaller refiners, but nearly everyone was in the 3x - 5x forward earnings range, not expensive, but for a cyclical, also not really that cheap. It turns out that, aside from the megacap refiners and $PARR, there's only one other US listed microcap refiner, Blue Dolphin Energy $BDCO. The stock is heavily insider owned, and at the time, was trading at just over 4x Q1 earnings ($0.99). Crack spreads are publicly viewable, and other refiners were demolishing estimates - $PARR came in at $11 in Q2, triple Q1, so it didn't take too much math to realize BDCO's Q2 was gonna be strong given jet fuel prices, and that the stock was potentially trading under 1x forward earnings. Of course, it's an OTC name with limited liquidity so you can't realize size it up, but how often do you get a chance to buy someone who supplies jet fuel to the Department of Defense under 1x annualized earnings? It was almost comedic, the story was funny enough to swallow the OTC stigma and just pick up a little bit up. About a week later, Q2 results came in at $1.19 (putting 1H earnings at ($2.18), and the market suddenly realized a stock trading at $4 on $2.18 of two quarter's EPS was just too cheap. The stock hit $18 today - I've been trimming since entry and am finally out. It was a tiny position, but I continue to find it ridiculous that these OTC setups exist. With a small amount of capital and a love for reading filings, you can probably find a slew of OTC names that are actually decently profitable that are simply too small for larger investors to take a stab at. I have no position in BDCO and have no opinion on it, $4 and $18 are totally different prices, but the fact this setup existed and somehow flew under the radar until earnings is pretty entertaining.

Investor Letters

All letters

House of Weichai

Weichai Power built a global engine group through Baudouin and a 46% stake in PSIX, positioning both for large-bore generator demand from…

PSIX $1.1B
Maius Partners 2 clicks

Diamond Estates: Research Note

Diamond Estates Wines & Spirits plans to expand grocery and export sales, invest in six brands, and improve winery operations through FY29.

LSDAF $1.1B
Atrium Research - Equity Research 2 clicks

Vizsla Silver (VZLA)

Vizsla Silver's Panuco project in Sinaloa remains shut after nine workers were found dead, delaying construction of a fully funded 17.4 Moz…

VZLA $1.9B
Triple S Special Situations Investing 1 click

Research Roundup Vol. LII

Dell’s AI-server demand and Microchip’s data-center components lead updates on Cirrus Logic and STMicroelectronics, alongside a weekly…

CRUS $6B
Monte Independent Investment Research

Alarm.com: False Alarm?

Alarm.com, founded after CEO Steve Trundle’s bad home-security experience, has fallen from $105 in 2020 to about $55, testing whether…

ALRM $2.7B
TSOH Investment Research 1 click

Publications we follow

Every publication on this site, hand-picked.

107 publications

Newsletters 90

YouTube 4

Blogs 12

Seeking Alpha 29 of 156

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

68 accounts
Nominate an account

Investor letters we follow

78 firms

Sectors

Ordered by how often our editor reaches for them.